# CVS HEALTH CORPORATION (CVS) FY2025 Q2 P&L / Income Statement

- Company: CVS HEALTH CORPORATION (CVS)
- Period: 2025-04-01 to 2025-06-30
- Filing: Q2 FY2025 10-Q, filed 2025-07-31, accession number 0000064803-25-000024
- Page: https://plicit.ai/financials/cvs/fy2025-q2-income-statement
- Chart image: https://plicit.ai/charts/cvs-fy2025-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2025-04-01 through 2025-06-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 98,915,000,000 US dollars
- **Total operating costs**: 96,534,000,000 US dollars
- **Operating income**: 2,381,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 734,000,000 US dollars
- **Income before income tax provision**: 1,647,000,000 US dollars
- **Income tax provision**: 634,000,000 US dollars
- **Net income**: 1,013,000,000 US dollars
- **Products**: 60,607,000,000 US dollars
- **Services**: 3,626,000,000 US dollars
- **Premiums**: 34,195,000,000 US dollars
- **Net investment income**: 487,000,000 US dollars
- **Cost of products sold**: 54,005,000,000 US dollars
- **Health care costs**: 31,317,000,000 US dollars
- **Operating expenses**: 11,212,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $1.02 B; to noncontrolling interests: −$8.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/cvs/fy2025-q2-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/cvs-fy2025-q2-revenue-by-business-segment-sankey.png

Income statement for 2025-04-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 98,915,000,000 US dollars
- **Total operating costs**: 96,534,000,000 US dollars
- **Operating income**: 2,381,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 734,000,000 US dollars
- **Income before income tax provision**: 1,647,000,000 US dollars
- **Income tax provision**: 634,000,000 US dollars
- **Net income**: 1,013,000,000 US dollars
- **Health Care Benefits**: 36,258,000,000 US dollars
- **Health Services**: 46,453,000,000 US dollars
- **Pharmacy & Consumer Wellness**: 33,581,000,000 US dollars
- **Cost of products sold**: 54,005,000,000 US dollars
- **Health care costs**: 31,317,000,000 US dollars
- **Operating expenses**: 11,212,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 116,292,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Health Care Benefits**: negative 20,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Health Services**: negative 6,338,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Pharmacy & Consumer Wellness**: negative 11,115,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Corporate/ Other**: 96,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CVS HEALTH CORPORATION: $1.02 B; to noncontrolling interests: −$8.00 M.